Systagenix introduces world's first rapid point of test in wound care

Starting from November Systagenix will unveil their new corporate look and brand identity.

“Brand Systagenix must reflect our passion and agility to drive innovation that has just one goal: to help heal wounds, fast. This is captured by our call to action: 'Let's Heal™', which represents our unique integrated wound healing system, built of four categories”

"Innovation doesn't come easy" says Steve Atkinson, Systagenix CEO "and neither do great brands, yet our team have been responsible for many innovations within this field over the last four decades. We are now introducing the world's first rapid point of care test in wound care to help clinicians choose the most appropriate dressings and therapies for their patients and monitor their efficacy over time. With over 20 million chronic wounds in the world every year, anyone close to the world of wound care knows this is going to be revolutionary. The introduction of wound diagnostics helps us to further develop our integrated wound healing system, by finally being able to provide "test & treat" algorithms".

Paolo Di Vincenzo, Systagenix Vice President of Global Marketing, adds: "Brand Systagenix must reflect our passion and agility to drive innovation that has just one goal: to help heal wounds, fast. This is captured by our call to action: 'Let's Heal™', which represents our unique integrated wound healing system, built of four categories:

'Let's Test™': to finally give wound care tools to aid a correct and timely diagnosis just like in any other area of medicine nowadays

'Let's Protect™': to protect from infection, with unique products, including SILVERCEL® NON-ADHERENT...the antimicrobial designed not to stick to wounds...

'Let's Promote™': to promote wound healing in ways that standard dressing can't do, and

'Let's Comfort™', to provide a comfortable and effective healing environment for all types of wounds."

Source:

Brand Systagenix

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study uncovers diversity of cancer-associated fibroblasts in skin cancer